Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arie Perry

Showing results (301-310 of 422) with videos related to

Pageof 43
Sort By:
Cancer Research|August 5, 2015
Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in GlioblastomaLiliana Soroceanu, Lisa Matlaf, Sabeena Khan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2011
Adult medulloblastoma comprises three major molecular variantsMarc Remke, Thomas Hielscher, Paul A Northcott, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 15, 2013
The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomasMalak Abedalthagafi, Joanna J Phillips, Grace E Kim, et al.
Neuro-Oncology|January 29, 2014
Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomasNesrin Sabha, Christiane B Knobbe, Majula Maganti, et al.
Neuro-Oncology|October 13, 2022
Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical featuresAbrar Choudhury, William C Chen, Calixto-Hope G Lucas, et al.
Journal of Neuro-Oncology|September 15, 2016
Expression and prognostic impact of immune modulatory molecule PD-L1 in meningiomaSeunggu J Han, Gerald Reis, Gary Kohanbash, et al.
Neuro-Oncology|August 30, 2024
cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomasFelix Sahm, Kenneth D Aldape, Priscilla K Brastianos, et al.
Journal of Neurosurgery|October 7, 2017
Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539Leland Rogers, Peixin Zhang, Michael A Vogelbaum, et al.
Brain Pathology (Zurich, Switzerland)|August 31, 2025
cIMPACT-NOW update 11: Proposal on adaptation of diagnostic criteria for IDH- and H3-wildtype diffuse high-grade gliomas and for posterior fossa ependymal tumorsPieter Wesseling, David Capper, Guido Reifenberger, et al.
JAMA Oncology|April 9, 2026
Prospective Genomic Profiling of Consecutive MeningiomasMinh P Nguyen, Kanish Mirchia, Brooke C Braman, et al.
Pageof 43

Showing results (301-310 of 422) with videos related to

Sort By:
Pageof 43
Cancer Research|August 5, 2015
Cytomegalovirus Immediate-Early Proteins Promote Stemness Properties in GlioblastomaLiliana Soroceanu, Lisa Matlaf, Sabeena Khan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2011
Adult medulloblastoma comprises three major molecular variantsMarc Remke, Thomas Hielscher, Paul A Northcott, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 15, 2013
The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomasMalak Abedalthagafi, Joanna J Phillips, Grace E Kim, et al.
Neuro-Oncology|January 29, 2014
Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomasNesrin Sabha, Christiane B Knobbe, Majula Maganti, et al.
Neuro-Oncology|October 13, 2022
Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical featuresAbrar Choudhury, William C Chen, Calixto-Hope G Lucas, et al.
Journal of Neuro-Oncology|September 15, 2016
Expression and prognostic impact of immune modulatory molecule PD-L1 in meningiomaSeunggu J Han, Gerald Reis, Gary Kohanbash, et al.
Neuro-Oncology|August 30, 2024
cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomasFelix Sahm, Kenneth D Aldape, Priscilla K Brastianos, et al.
Journal of Neurosurgery|October 7, 2017
Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539Leland Rogers, Peixin Zhang, Michael A Vogelbaum, et al.
Brain Pathology (Zurich, Switzerland)|August 31, 2025
cIMPACT-NOW update 11: Proposal on adaptation of diagnostic criteria for IDH- and H3-wildtype diffuse high-grade gliomas and for posterior fossa ependymal tumorsPieter Wesseling, David Capper, Guido Reifenberger, et al.
JAMA Oncology|April 9, 2026
Prospective Genomic Profiling of Consecutive MeningiomasMinh P Nguyen, Kanish Mirchia, Brooke C Braman, et al.
Pageof 43